Physician profile
William Emper
NPI 1982664793
$1,078.34
in general payments reported to CMS, 2019-2025
9 companies · $471 in 2025
The $471 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.04 · 2020: $93.53 · 2022: $46.30 · 2023: $190 · 2024: $224 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $425.54 | 2019-2025 | Gel-One Cross-Linked Hyaluronate |
| Ferring Pharmaceuticals INC. | $268.61 | 2022-2025 | Euflexxa |
| Stryker Corporation | $100.98 | 2020-2025 | Variax, Pangea, Triathlon |
| Smith+Nephew, INC. | $82.90 | 2022-2024 | Evos, Lens 4k, Na |
| Ermi LLC | $62.65 | 2020-2023 | |
| Depuy Synthes Sales INC. | $60.91 | 2019-2025 | Orthovisc |
| Fidia Pharma USA INC. | $44.33 | 2025 | Hymovis |
| Pacira Pharmaceuticals Incorporated | $18.51 | 2023 | Zilretta, Iovera, Exparel |
| Heron Therapeutics, INC. | $13.91 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Emper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.